Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cell Mol Biol (Noisy-le-grand) ; 65(5): 3-8, 2019 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-31304900

RESUMEN

Cyclotrichium niveum is an endemic plant for Turkey and it appears to have in vitro antioxidant and acetylcholinesterase inhibition properties. To the best of our knowledge, there has been no study on the in vivo effects of this plant. Therefore, the purpose of this study was to evaluate the effects of C. niveum on lead (Pb)-acetate-induced potential alterations in brain acetylcholinesterase activity, as well as oxidative stress in male rats. The rats were randomly assigned to control, Pb-acetate, C. niveum and Pb-acetate+ C. niveum groups. Pb-acetate was provided in drinking water (500 ppm), and C. niveum was administered via orogastric gavage (4 ml/kg) for 30 days. The acetylcholinesterase activity in the brain significantly decreased only in the Pb-acetate group. The malondialdehyde level significantly increased, and the reduced glutathione activity decreased in the Pb-acetate group. The reduced glutathione and glutathione-S-transferase activities of the C. niveum group were higher than the control group. No Pb was detected on a ppb level in the brain tissue of the control and C. niveum groups, while it was detected in the brains of the rats in the Pb-acetate and Pb-acetate+ C. niveum groups (185+8.98 ppb and 206+56.65 ppb, respectively). The data collected in this study suggested that C. niveum may reduce inhibition of brain AChE activity and oxidative stress against Pb-acetate-induced alterations in the brain of male rats.


Asunto(s)
Acetilcolinesterasa/metabolismo , Antioxidantes/farmacología , Encéfalo/metabolismo , Inhibidores de la Colinesterasa/farmacología , Lamiaceae/química , Fármacos Neuroprotectores/farmacología , Compuestos Organometálicos/administración & dosificación , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Administración Oral , Animales , Glutatión/metabolismo , Glutatión Reductasa/metabolismo , Glutatión Transferasa/metabolismo , Masculino , Malondialdehído/metabolismo , Compuestos Organometálicos/efectos adversos , Ratas , Ratas Wistar , Turquía
2.
Arch Physiol Biochem ; 124(1): 80-87, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28817314

RESUMEN

In this study, the effect of geraniol (50 mg/kg for 30 d), a natural antioxidant and repellent/antifeedant monoterpene, in a rat model of lead acetate-induced (500 ppm for 30 d) liver damage was evaluated. Hepatic malondialdehyde increased in the lead acetate group. Reduced glutathione unchanged, but glutathione S-transferase, glutathione reductase, as well as carboxylesterase activities decreased in geraniol, lead acetate and geraniol + lead acetate groups. 8-OhDG immunoreactivity, mononuclear cell infiltrations and hepatic lead concentration were lower in the geraniol + lead acetate group than the lead acetate group. Serum aspartate aminotransferase and alanine aminotransferase activities increased in the Pb acetate group. In conclusion, lead acetate causes oxidative and toxic damage in the liver and this effect can reduce with geraniol treatment. However, we first observed that lead acetate, as well as geraniol, can affect liver carboxylesterase activity.


Asunto(s)
Carboxilesterasa/antagonistas & inhibidores , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Repelentes de Insectos/uso terapéutico , Intoxicación por Plomo/prevención & control , Hígado/efectos de los fármacos , Sustancias Protectoras/uso terapéutico , Terpenos/uso terapéutico , Monoterpenos Acíclicos , Animales , Antioxidantes/efectos adversos , Antioxidantes/uso terapéutico , Biomarcadores/sangre , Biomarcadores/metabolismo , Carboxilesterasa/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/enzimología , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Enfermedad Hepática Inducida por Sustancias y Drogas/fisiopatología , Glutatión/química , Glutatión/metabolismo , Glutatión Reductasa/metabolismo , Glutatión Transferasa/metabolismo , Repelentes de Insectos/efectos adversos , Intoxicación por Plomo/metabolismo , Intoxicación por Plomo/patología , Intoxicación por Plomo/fisiopatología , Peroxidación de Lípido/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Hígado/fisiopatología , Masculino , Compuestos Organometálicos/antagonistas & inhibidores , Compuestos Organometálicos/toxicidad , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Sustancias Protectoras/efectos adversos , Distribución Aleatoria , Ratas Wistar , Terpenos/efectos adversos
3.
J Biochem Mol Toxicol ; 31(9)2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28467669

RESUMEN

Testis tissue is prone to oxidation because its plasma membrane contains many polyunsaturated fatty acids. Naringenin is a plant-derived natural flavonoid. We investigated the possible ameliorative role of naringenin on the hydrogen peroxide (H2 O2 )-induced testicular damage in Wistar rats. Animals received 12 mg/kg H2 O2 by intraperitoneal injection, and 50 mg/kg naringenin via orogastric gavage for 4 weeks. In the H2 O2 group, the testis malondialdehyde level increased, while the amount of reduced glutathione, glutathione transferase activities, and the testis weight decreased. There were severe testicular damages in the H2 O2 group otherwise their grade were less in the naringenin + H2 O2 group. However, the serum testosterone concentrations decreased in both the H2 O2 and the naringenin + H2 O2 groups. The testicular zinc and calcium levels reduced in the H2 O2 -treated rats. In conclusion, the administration of H2 O2 caused oxidative stress in the testes and naringenin supplementation decreased the H2 O2 -induced effects, except for changes in testosterone levels.


Asunto(s)
Flavanonas/farmacología , Peróxido de Hidrógeno/toxicidad , Estrés Oxidativo/efectos de los fármacos , Testículo/metabolismo , Animales , Glutatión/metabolismo , Glutatión Transferasa/metabolismo , Masculino , Ratas , Ratas Wistar , Testículo/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA